www.fdanews.com/articles/98107-dr-reddy-rsquo-s-launches-ebernet-in-india
Dr. Reddy’s Launches Ebernet in India
September 6, 2007
Indian drugmaker Dr. Reddy’s announced the launch of Ebernet, marking the entry of Dr. Reddy’s into topical antifungal market.
Ebernet (eberconazole 1 percent cream) is indicated in the treatment of superficial fungal infections. The drug is licensed from the innovator company, Salvat Laboratories of Spain.
Eberconazole is an imidazole derivate that inhibits the synthesis of ergosterol and has antifungal as well as potent anti-inflammatory effects.